MPS Pharmaa Ltd (531686)
- Market Cap
- ₹4
- P/B Ratio
- 56.79
- ROE
- -1485.7%
- ROCE
- -14.1%
- Debt/Equity
- 107.43
- Promoter
- 35.9%
📊 Quarterly Results (₹ Cr)
| Metric | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | -0 | -0 | -0 | -0 | -0 |
| OPM % | — | — | — | — | — |
| Net Profit | -0 | -0 | -0 | -0 | -0 |
| EPS | ₹-0.11 | ₹-0.12 | ₹-0.12 | ₹-0.19 | ₹-0.12 |
🏦 Balance Sheet (₹ Cr)
| Item | Mar 2025 | Mar 2025 | Mar 2026 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 19 | 19 | 19 | 19 |
| Reserves | -18 | -18 | -19 | -18 |
| Borrowings | 7 | 7 | 8 | 8 |
| Total Liabilities | 9 | 10 | 8 | 9 |
| Fixed Assets | 4 | 4 | 4 | 4 |
| Investments | 1 | 1 | 1 | 1 |
| Total Assets | 9 | 10 | 8 | 9 |
💰 Cash Flow Statement (₹ Cr)
| Item | Mar 2025 |
|---|---|
| Operating | -1 |
| Investing | +0 |
| Financing | +0 |
| Net Cash Flow | -0 |
👥 Shareholding Pattern
| Category | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|
| Promoters | 35.9% | 35.9% | 35.9% | 35.9% |
| FII | 0.0% | 0.0% | 0.0% | 0.0% |
| DII | 0.6% | 0.6% | 0.6% | 0.6% |
| Public | 37.1% | 37.1% | 37.9% | 37.9% |
| # Shareholders | 4,433 | 4,425 | 4,419 | 4,409 |
⚖️ Peer Comparison — Pharmaceuticals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| SUNPHARMA | 4.37 L Cr | 36.1 | 18.7% | — | 0.05 |
| DIVISLAB | 2.46 L Cr | 84.2 | 23.0% | — | 0.00 |
| TORNTPHARM | 1.83 L Cr | 76.6 | 15.1% | — | 1.76 |
| ZYDUSLIFE | 1.16 L Cr | 25.9 | 16.8% | — | 0.43 |
| CIPLA | 1.09 L Cr | 32.3 | 13.2% | — | 0.01 |
| LAURUSLABS | 1.07 L Cr | 97.8 | 20.8% | — | 0.45 |
| MANKIND | 1.03 L Cr | 50.6 | 13.9% | — | 0.38 |
| DRREDDY | 1.03 L Cr | 31.9 | 10.1% | — | 0.17 |
| AUROPHARMA | 95,887 | 26.0 | 12.8% | — | 0.20 |
| LUPIN | 93,367 | 16.5 | 27.9% | — | 0.26 |
🔗 Peer Stock Analyses
📋 Recent Filings
- 🟡 voting results2026-10-01At the 32nd Annual General Meeting held on September 29, 2026, shareholders approved all proposed resolutions, including the adoption of the financial…
- 🟡 Board Meeting2026-09-29MPS Pharmaa held its 32nd AGM on September 29, 2026, adopting audited FY2026 financials, reappointing directors, and approving related party transacti…
- Announcement2026-09-26MPS Pharmaa Ltd announced that its trading window will close on 1 October 2026 for all insiders until 48 hours after the unaudited quarterly results f…
- Announcement2026-09-26MPS Pharmaa Ltd announced that its trading window will close on 1 October 2026 for all insiders until 48 hours after the unaudited quarterly results f…
- 🟡 Board Meeting2026-09-07MPS Pharmaa announced a book closure from September 23 to 29, 2026, to facilitate its Annual General Meeting, affecting share transfer records during …
- 🟡 Board Meeting2026-09-07MPS Pharmaa announced a book closure from September 23 to 29, 2026, to facilitate its Annual General Meeting, affecting share transfer records during …
- 🟡 Board Meeting2026-09-05MPS Pharmaa Limited announced its 32nd Annual General Meeting on 29 September 2026 at 09:30 AM IST at its registered office in Sohna, Haryana. The mee…
- 🔴 annual report2026-09-05MPS Pharmaa Limited reported a net loss of **[amount context mismatch] crore** for FY 2025-26, with no dividend recommended due to losses and no reser…
- 🔴 annual report2026-09-05MPS Pharmaa Limited announced that its FY2025-26 Annual Report is now available on its website via a dedicated web link and QR code, and shareholders …
- 🟡 Board Meeting2026-09-02MPS Pharmaa announced its 32nd AGM will be held on 29 September 2026 at 09:30 AM at its registered office in Sohna, Haryana. The board approved the no…
Read the full analysis
Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.
Sign Up Free — Unlock Full Analysis2 free AI queries per day.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-10-01.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day